111 related articles for article (PubMed ID: 23259994)
61. Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin.
Mariadason JM; Arango D; Shi Q; Wilson AJ; Corner GA; Nicholas C; Aranes MJ; Lesser M; Schwartz EL; Augenlicht LH
Cancer Res; 2003 Dec; 63(24):8791-812. PubMed ID: 14695196
[TBL] [Abstract][Full Text] [Related]
62. MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism.
Pereira DM; Simões AE; Gomes SE; Castro RE; Carvalho T; Rodrigues CM; Borralho PM
Oncotarget; 2016 Jun; 7(23):34322-40. PubMed ID: 27144434
[TBL] [Abstract][Full Text] [Related]
63. [Drug resistance of colon cancer cells to 5-fluorouracil mediated by microRNA-21].
Wu L; Li S; Peng R; Gong S; Xu L; Zou F
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Oct; 32(5):620-4. PubMed ID: 26418978
[TBL] [Abstract][Full Text] [Related]
64. Vitamin C enhances chemosensitization of esophageal cancer cells in vitro.
Abdel-Latif MM; Raouf AA; Sabra K; Kelleher D; Reynolds JV
J Chemother; 2005 Oct; 17(5):539-49. PubMed ID: 16323444
[TBL] [Abstract][Full Text] [Related]
65. Combining siRNAs at two different sites in the EGFR to suppress its expression, induce apoptosis, and enhance 5-fluorouracil sensitivity of colon cancer cells.
Wu X; Deng Y; Wang G; Tao K
J Surg Res; 2007 Mar; 138(1):56-63. PubMed ID: 17169374
[TBL] [Abstract][Full Text] [Related]
66. Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth.
Sakamoto K; Maeda S; Hikiba Y; Nakagawa H; Hayakawa Y; Shibata W; Yanai A; Ogura K; Omata M
Clin Cancer Res; 2009 Apr; 15(7):2248-58. PubMed ID: 19276252
[TBL] [Abstract][Full Text] [Related]
67. [Effects of expression of thymidine phosphorylase induced by gamma-interferon on regulation of antineoplastic activity of fluorouracil on colonic cancer].
Yu XQ; Deng CS; Zhu YQ; Cheng FZ
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):568-70. PubMed ID: 15949342
[No Abstract] [Full Text] [Related]
68. MicroRNA-21-mediated regulation of Sprouty2 protein expression enhances the cytotoxic effect of 5-fluorouracil and metformin in colon cancer cells.
Feng YH; Wu CL; Shiau AL; Lee JC; Chang JG; Lu PJ; Tung CL; Feng LY; Huang WT; Tsao CJ
Int J Mol Med; 2012 May; 29(5):920-6. PubMed ID: 22322462
[TBL] [Abstract][Full Text] [Related]
69. Treatment of colon and breast carcinoma cells with 5-fluorouracil enhances expression of carcinoembryonic antigen and susceptibility to HLA-A(*)02.01 restricted, CEA-peptide-specific cytotoxic T cells in vitro.
Correale P; Aquino A; Giuliani A; Pellegrini M; Micheli L; Cusi MG; Nencini C; Petrioli R; Prete SP; De Vecchis L; Turriziani M; Giorgi G; Bonmassar E; Francini G
Int J Cancer; 2003 Apr; 104(4):437-45. PubMed ID: 12584740
[TBL] [Abstract][Full Text] [Related]
70. Differential interference of vitamin D analogs PRI-1906, PRI-2191, and PRI-2205 with the renewal of human colon cancer cells refractory to treatment with 5-fluorouracil.
Kotlarz A; Przybyszewska M; Swoboda P; Miłoszewska J; Grygorowicz MA; Kutner A; Markowicz S
Tumour Biol; 2016 Apr; 37(4):4699-709. PubMed ID: 26511971
[TBL] [Abstract][Full Text] [Related]
71. Proliferation rate but not mismatch repair affects the long-term response of colon carcinoma cells to 5FU treatment.
Choudhary B; Hanski ML; Zeitz M; Hanski C
Cancer Lett; 2012 Jul; 320(1):56-64. PubMed ID: 22266192
[TBL] [Abstract][Full Text] [Related]
72. H3K9 Trimethylation Silences Fas Expression To Confer Colon Carcinoma Immune Escape and 5-Fluorouracil Chemoresistance.
Paschall AV; Yang D; Lu C; Choi JH; Li X; Liu F; Figueroa M; Oberlies NH; Pearce C; Bollag WB; Nayak-Kapoor A; Liu K
J Immunol; 2015 Aug; 195(4):1868-82. PubMed ID: 26136424
[TBL] [Abstract][Full Text] [Related]
73. Enhanced radiosensitization and chemosensitization in NF-kappaB-suppressed human oral cancer cells via the inhibition of gamma-irradiation- and 5-FU-induced production of IL-6 and IL-8.
Tamatani T; Azuma M; Ashida Y; Motegi K; Takashima R; Harada K; Kawaguchi S; Sato M
Int J Cancer; 2004 Mar; 108(6):912-21. PubMed ID: 14712497
[TBL] [Abstract][Full Text] [Related]
74. Inhibition of nuclear factor-κB activity by small interfering RNA in esophageal squamous cell carcinoma cell lines.
Hatata T; Higaki K; Nanba E; Tatebe S; Ikeguchi M
Oncol Rep; 2011 Sep; 26(3):659-64. PubMed ID: 21617867
[TBL] [Abstract][Full Text] [Related]
75. High expression of thymidylate synthase leads to resistance to 5-fluorouracil in biliary tract carcinoma in vitro.
Habara K; Ajiki T; Kamigaki T; Nakamura T; Kuroda Y
Jpn J Cancer Res; 2001 Oct; 92(10):1127-32. PubMed ID: 11676864
[TBL] [Abstract][Full Text] [Related]
76. In vino, curationis?
MacLachlan TK
Cancer Biol Ther; 2008 Aug; 7(8):1313-4. PubMed ID: 18719359
[No Abstract] [Full Text] [Related]
77. The relationship between tumor metabolism and 5-fluorouracil resistance.
Hu J; Li A; Guo Y; Ma T; Feng S
Biochem Pharmacol; 2023 Dec; 218():115902. PubMed ID: 37922975
[No Abstract] [Full Text] [Related]
78. Role of pH in tumor-trapping of the anticancer drug 5-fluorouracil.
McSheehy PM; Stubbs M; Griffiths JR
Adv Enzyme Regul; 2000; 40():63-80. PubMed ID: 10828346
[No Abstract] [Full Text] [Related]
79. Effect of 5-fluorouracil on polyamine excretion in human colonic cancer cells.
Mackarel AJ; Wallace HM
Biochem Soc Trans; 1993 Feb; 21(1):50S. PubMed ID: 8449334
[No Abstract] [Full Text] [Related]
80. Looking for the right drug for the right patient: a tale of old drugs and new pathways.
Alba E; Ribelles N
Clin Transl Oncol; 2005 Oct; 7(9):375-6. PubMed ID: 16238971
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
